Compare ROIV & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROIV | PSN |
|---|---|---|
| Founded | 2014 | 1944 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 9.2B |
| IPO Year | N/A | 2019 |
| Metric | ROIV | PSN |
|---|---|---|
| Price | $22.15 | $64.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $21.19 | ★ $85.75 |
| AVG Volume (30 Days) | ★ 6.5M | 1.9M |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.02 |
| EPS | N/A | ★ 2.17 |
| Revenue | $20,329,000.00 | ★ $6,494,748,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $376.94 | $5.69 |
| P/E Ratio | ★ N/A | $30.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $54.56 |
| 52 Week High | $22.05 | $99.04 |
| Indicator | ROIV | PSN |
|---|---|---|
| Relative Strength Index (RSI) | 68.27 | 26.39 |
| Support Level | $20.14 | $61.85 |
| Resistance Level | $21.48 | $67.36 |
| Average True Range (ATR) | 0.66 | 2.83 |
| MACD | -0.02 | -1.97 |
| Stochastic Oscillator | 87.53 | 8.17 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.